NARCAN® Nasal Spray is a pure opioid antagonist indicated for emergency use to reverse known or suspected opioid overdose, as manifested by respiratory and/or severe central nervous system depression. While NARCAN® Nasal Spray can be administered by a non-health care professional, it is not intended to be a substitute for professional medical care. Always call 911 as soon as an opioid overdose is suspected, before administering NARCAN® Nasal Spray. Read the label and follow the directions for use for NARCAN® Nasal Spray. Please consult the Product Monograph for contraindications, warnings, precautions, adverse reactions, drug interactions, dosing guidelines, and conditions of clinical use at https://narcannasalspray.ca/pdf/NARCAN%C2%AE-Nasal-Spray-product-monograph-Mar%2005-2021-red-plunger.pdf. Distributed by Emergent BioSolutions Canada Inc. Mississauga, ON L5N 6M1.
© 2024 Emergent BioSolutions Canada Inc., a wholly owned subsidiary of Emergent BioSolutions Inc. NARCAN® is a registered trademark of Emergent Operations Ireland Limited, which is a subsidiary of Emergent BioSolutions Inc. EMERGENT® and any and all Emergent BioSolutions Inc. brands, products, services and feature names, logos and slogans are trademarks or registered trademarks of Emergent BioSolutions Inc. or its subsidiaries in the United States or other countries. PP-NAR4-CA-00248-03/2024
